NCT02489942View on ClinicalTrials.gov

Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

8,145

Participants

Timeline

Start Date

June 12, 2015

Primary Completion Date

November 11, 2020

Study Completion Date

December 4, 2020

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Jardiance

Empagliflozin

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY